Taysha Gene Therapies, Inc. Share Price

Taysha Gene Therapies, Inc. Share Price

NASDAQ: TSHA | Small Cap
$4.22
-$0.02 (-0.35%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Taysha Gene Therapies, Inc. Stock Performance

Open
$4.27
Prev. Close
$4.24
Circuit Range
N/A
Day Range
$4.14 - $4.47
Year Range
$3.47 - $7.30
Volume
1,56,177
Average Traded
$4.30

Taysha Gene Therapies, Inc. Share Price Today

As of 30 October 2026, Taysha Gene Therapies, Inc.'s share price is $4.22. The stock opened at $4.27, compared to its previous close of $4.24. During today's trading session, Taysha Gene Therapies, Inc.'s share price traded between $4.14 and $4.47, with an average price of $4.30. Over the past 52 weeks, the stock has recorded a high of $7.30 and a low of $3.47. In terms of performance, Taysha Gene Therapies, Inc.'s share price has declined by 33.75% over the last six months and is down 14.92% on a year-on-year basis.

Taysha Gene Therapies, Inc. Share Price Chart

Line chart of the Taysha Gene Therapies, Inc. price trend over the selected period. The price fell overall, ranging from 4.14 to 4.46, ending at 4.22.
$4.14$4.47
L
Show Current Price
H

Taysha Gene Therapies, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.35B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.46
Revenue (TTM)
$9.77B
Return On Equity (TTM)
-38.64%
Profit Margin
-1115.66%
Debt to Equity
0.13
Quarterly Earnings Growth YoY
-42.50%

Taysha Gene Therapies, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$5.49$0.00$0.00
Net Profit-$32.73-$27.85-$42.41-$46.64
Net Profit MarginN/A-507.29%N/AN/A
Income ChangeN/A14.91%-52.28%-9.97%

Taysha Gene Therapies, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.50$15.45$8.33$9.77
Net Profit-$166.01-$111.57-$89.30-$109.00
Net Profit Margin-6640.40%-722.14%-1072.03%-1115.66%
Income ChangeN/A32.79%19.96%-22.06%

About Taysha Gene Therapies, Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Taysha Gene Therapies, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.83
$4.24
-13.04%
Sep 2026
$5.63
$4.87
-18.15%
Aug 2026
$5.90
$5.95
+1.45%
Jul 2026
$6.71
$5.87
-13.94%
Jun 2026
$5.79
$6.82
+16.50%
May 2026
$6.33
$5.85
-8.16%
Apr 2026
$4.41
$6.37
+42.99%
Mar 2026
$4.47
$4.46
-1.87%
Feb 2026
$4.61
$4.54
+0.55%
Jan 2026
$5.48
$4.51
-17.76%
Dec 2025
$4.60
$5.49
+15.82%
Nov 2025
$4.33
$4.74
-4.44%

TSHA Share Price FAQs